Lefebvre R

No ORCID on file · 1 paper in corpus
2025
Frontiers in reproductive health ·doi:10.3389/frph.2025.1650946

BackgroundAround 20% of patients undergoing assisted reproductive technology are at risk of hypo-response to ovarian stimulation. The aim of this study was to describe the real-world use of follitropin delta for ovarian stimulation in these…